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Abstract: We present a patient with longstanding ankylosing spondylitis complicated with cauda equina syndrome. The 
patient suffered from increasing pain in the leg with reduced sensitivity and extremely cold feet associated with 
incontinence. Diagnostic workup revealed dural ectasia, arachnoiditis and a spinal inflammatory mass leading to extensive 
vertebral bone destruction. Of interest, this was not only found in the lumbar spine region (which is typical in cases of 
cauda equina syndrome associated with ankylosing spondylitis) but also in the lower cervical spine (C7) and upper dorsal 
spine. Moreover, the bone destructive phenotype of this complication of long-standing AS contrasts with the usual 
characteristics of new bone formation and ankylosis. As initial treatment with anti-inflammatory drugs was not 
sufficiently successful, infliximab therapy was started which resulted in manifest clinical improvement as chronic pain, 
incontinence and laboratory signs of inflammation progressively disappeared. 
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INTRODUCTION 
  Dural ectasia and arachnoiditis, sometimes leading to 
cauda equina syndrome, are rare complications of ankylosing 
spondylitis and can be a diagnostic and therapeutic challenge 
[1-5]. Here, we present a patient in whom dural ectasia is 
accompanied by remarkable bone destruction both in the 
cervical, dorsal and lumbar spine. 
CASE 
  A 73-year-old male was referred to the outpatient 
spondyloarthritis clinic by his general practitioner. He was 
diagnosed with ankylosing spondylitis in his early twenties 
and had been treated for decades with phenylbutazone and 
sulfasalazine. For the last 10 years he had not been under the 
specific care of a rheumatologist. 
  His medical history further included two pneumonias (in 
1984 and 1997), surgery for inguinal herniation and benign 
prostate hypertrophy. He was also treated for hypertension 
(bisoprolol, hydrochlorothiazide and lisinopril) and 
hypercholesterolemia (simvastatine). One year before this 
referral, treatment with phenylbutazone was stopped as the 
product was no longer commercially available. 
  He suffered from increasing pain in the left leg and foot 
over the last 6 months, and also mentioned loss of sensitivity 
in the leg and extremely cold feet. Pain increased in 
recumbent position, in particular at night, and disappeared 
upon walking or biking. On further questioning the patient 
indicated urinary and fecal incontinence. The urinary 
incontinence was previously attributed to benign prostate 
hypertrophy, for which he underwent a transurethral 
procedure in 2006. However, this procedure did not result in 
significant subjective improvement. 
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  Clinical examination revealed loss of axial mobility with 
a modified Schöber index of 0.5 cm, a lumbar lateroflexion 
of 2.0 cm, tragus to wall distance of 28.0 cm and a cervical 
rotation of 10°. We also noted extremely cold feet with 
reduced sensibility in the left foot, normal arterial pulsations 
of the arteria femoralis and arteria tibialis posterior but 
bilateral absence of pulsations in the arteria dorsalis pedis. 
  Biochemistry showed C-reactive protein (CRP) levels of 
18.4 mg/dl (reference value < 5 mg/dl) and an Erythrocyte 
Sedimentation Rate (ESR) of 21 mm/hour (reference value < 
10 mm/h). Further vascular investigation included an 
angiography by nuclear magnetic resonance imaging (MRI) 
that showed normal aorto-iliacal, femoral and popliteal 
vessels. X-ray of the lower back region showed bilateral 
grade IV sacroiliitis and a bamboo spine (Fig. 1a). The axis 
of the lumbar spine was shifted to the left. As lumbar 
stenosis was suspected, computed tomography (CT) of the 
lumbar spine and electromyography (EMG) were performed. 
CT revealed dural ectasia with osteolysis of the arcus 
posterior from lumbar vertebra 1 to 4 and extending into the 
spinal canal (Fig. 1b,  c). EMG confirmed bilateral 
denervation in S1 and unilateral re-innervation of L4-S1, and 
L5-S1 on the left and right side respectively. MRI of the 
lumbar spine region showed a bamboo spine with active 
inflammation in the vertebrae (Fig. 1d). Dural ectasia was 
confirmed and sequelae of arachnoiditis were suspected, in 
particular the existence of a mass in the cauda equina in 
continuity with the dura (Fig. 1d). 
  During the diagnostic work-up, the patient was admitted 
to the hospital because of bilateral community acquired 
pneumonia, successfully treated with intravenous antibiotics. 
Rehabilitation with physiotherapy during the hospital stay 
improved some of the symptoms and treatment with 
phenylbutazone on demand was reinstalled with good 
results. The general condition of the patient further 
suggested a conservative approach. Out patient visits 
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  A few months after his stay at our ward, the patient fell at 
home and was hospitalized elsewhere. His major complaint 
consisted in increasing dorsal pain for which he underwent 
an MRI of the dorsal spine. The MRI described an image of 
bone remodeling in C7, D3, D4 and D5 and a soft 
paravertebral tissue mass on the right side of D3 (Fig. 2a). 
After transfer to our clinic, CT showed osteolytic lesions in 
D3, D4 and D5 (corpus, processus spinosus and processus 
transversus) with diffuse cortical damage and destruction of 
the posterior wall of the vertebrae (Fig. 2b-d). The presence 
of a prevertebral mass on the right side (3.3 x 1.7 x 2.7cm) 
was confirmed (Fig. 2c, d). We thus diagnosed a process in 
the dorsal spine largely similar to that seen earlier in the 
lumbar spine with active arachnoiditis, intraspinal cysts and 
bone erosion. 
  Further deterioration of the general status of this patient 
occurred. Since we found evidence for active inflammation 
of the spine (on MRI and biochemistry) we decided to start 
treatment with infliximab at a dosing scheme of 5 mg/kg 
(w0, w2, w6). BASDAI at onset was 4.9/10. After 3 
infusions it lowered to 3.1/10. Inflammation in the blood 
disappeared and there was a noticable clinical improvement 
with complete recuperation of the faecal incontinence and 
the disappearance of back pain. The loss of sensitivity in the 
left leg however persisted. 
DISCUSSION 
  Neurological manifestations of AS are rare and occur in 
approximately 2.1% of patients [2, 3]. Cauda equina 
syndrome has been described as a complication of long-
 
Fig. (1). Imaging of the lumbar spine. (a) Longstanding disease resulted in a characteristic bamboo spine with ankylosis and osteoporosis. 
(b) CT imaging revealed dural ectasia with osteolysis of the arcus posterior from lumbar vertebra 1 to 4 (L1-4) and extending into the spine 
channel (arrow) on a sagittal view. (c) Transverse CT section showing arcus destruction in L3 (arrow). (d) Short TI Inversion Recovery 
(STIR) MRI images show inflammation in the vertebral bodies (arrowheads) and arachnoiditis with a contrast capturing mass in the cauda 
equine in continuity with the dura (arrow). CES in AS  The Open Rheumatology Journal, 2010, Volume 4   33 
standing ankylosing spondylitis. At the time of diagnosis 
most patients do not show any inflammation in the blood, or 
on MRI [2-9], but in the case presented here signs of active 
inflammation were detected. 
  Cauda equina syndrome (CES) is considered a serious 
neurological condition with progressive loss of function of 
the neurologic elements of the spinal canal below the 
termination of the spinal cord. Common causes of CES are 
prolaps of an intervertebral disc, metastatic disease, direct 
trauma from lumbar puncture and spinal anesthesia. Also 
penetrating wounds, spinal stenosis due to a degenerative 
process, development defects and inflammatory conditions 
such as Paget’s disease and ankylosing spondylitis can cause 
CES [4]. 
  The pathogenesis of CES remains unclear. Possible 
pathogenic mechanisms include inflammation and 
arachnoiditis (with subsequent fibrosis and formation of 
dural ectasia), mechanical stretching and compression of the 
nerve roots (by dural ectasia or arachnoid cysts, or secondary 
to an arterial pulse wave), reduced compliance of the caudal 
sac and a demyelination due to radiotherapy or ischaemia [2-
10]. 
  In this case chronic arachnoiditis with formation of dural 
ectasia and subsequent loss of meningeal elasticity is a likely 
mechanism for the CES. Furthermore, arachnoiditis does not 
only affect the lower spine, but is also present in the upper 
regions. MRI of the cervical and dorsal spine indicates active 
arachnoiditis. Dural ectasia and osteolysis at this level were 
not as severe as in the lumbar spine, suggesting that these 
findings might represent an earlier phase in the disease 
process. 
  This is the first case where dural ectasia and osteolysis 
are described in lower cervical spine (C7), upper dorsal and 
lumbar spine. In the literature, non-lumbar localization of 
dural ectasia has been seen in the cervical and thoracic 
region in patients with neurofibromatosis [11] but not yet in 
ankylosing spondylitis. 
  The osteolytic, bone-destructive changes are remarkable 
as ankylosing spondylitis is typically associated with bone 
formation rather than destruction [12]. The link between 
arachnoiditis and bone destruction of the posterior elements 
 
Fig. (2). Imaging of the cervical and dorsal spine. (a) Soft tissue prevertebral mass on the right side of dorsal vertebra 3 (D3) visualized by 
STIR MRI. (b) Sagital CT image showing osteolytic lesions (arrow) in vertebrae D3, D4 and D5 (corpus, processus spinosus and 
transversus) with diffuse cortical involvement and destruction of the posterior wall. (c) Sagital CT image showing the prevertebral mass on 
the right side (3.3x1.7x2.7cm) (arrow). (d) Transverse CT image showing osteolytic destruction (arrow). 34   The Open Rheumatology Journal, 2010, Volume 4  Van Hoydonck et al. 
further supports an inflammatory stimulus for bone 
destruction in particular a role for osteoclasts [13]. 
  In conclusion, dura and cauda equina involvement are 
rare complications of long-standing ankylosing spondylitis. 
In this patient inflammation apparently resulted in a bone 
destructive mass in both lower cervical (C7), upper dorsal 
and lumbar spine, which is a very unusual phenotype for 
ankylosing spondylitis. If neurologic deficits occur in 
patients with long-standing AS a complete neurologic work-
up, as well as MRI of the spine are indicated. 
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